Breztri Aerosphere : Astra Zeneca
Company Name: AstraZeneca Therapeutic Use: Obstructive compulsive disorder The Breztri is a new combination drug derived by AstraZeneca used for the obstructive compulsive disorder. The breztri consist of inhaled corticosteroid Budesonide and long acting anti-cholinergic agent Formetrol fumarate. The inhaled corticosteroid budesonide helps to decrease inflammation in lungs which can lead to breathing problem. The anticholinergic drug is useful in relaxing lung muscle. Breztri can be used for the patient in COPD. It can be used as 2 inhalation 2 times a day and 2 puff to improve COPD symptoms.
